Hannaford Alisse, Hernandez-Acosta Ruben Alfonso, Little Jessica S, Campbell Jeffrey I, Weiss Zoe F, Sherman Amy C
Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA; Department of Internal Medicine, Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.
Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA.
Clin Lab Med. 2025 Mar;45(1):27-40. doi: 10.1016/j.cll.2024.10.009. Epub 2024 Nov 16.
This review highlights the current state of molecular diagnostic modalities to detect invasive fungal infections, with a focus on molds in immunocompromised children and adults. Molecular diagnostics may also be utilized to detect antifungal drug resistance. Although both pathogen-specific and pathogen-agnostic assays may be beneficial in more rapidly identifying fungal infection with less invasive sampling in high-risk populations, the clinical implementation and interpretation of these tests must consider several important factors, including anatomic site and type of specimen, host characteristics, use of antifungal prophylaxis, and timing of specimen collection.
本综述重点介绍了检测侵袭性真菌感染的分子诊断方法的现状,重点关注免疫功能低下儿童和成人中的霉菌。分子诊断也可用于检测抗真菌药物耐药性。尽管病原体特异性和非病原体特异性检测在高危人群中以侵入性较小的采样方式更快速地识别真菌感染方面可能都有益处,但这些检测的临床应用和解读必须考虑几个重要因素,包括解剖部位和标本类型、宿主特征、抗真菌预防用药的使用情况以及标本采集时间。